" /> AC Followed by Docetaxel/Trastuzumab Regimen - CISMeF





Preferred Label : AC Followed by Docetaxel/Trastuzumab Regimen;

NCIt synonyms : Doxorubicin/Cyclophosphamide Followed by Docetaxel/Trastuzumab; AC-T Plus Trastuzumab; AC Followed by Docetaxel Trastuzumab; AC-TH; Doxorubicin/Cyclophosphamide Followed by Docetaxel Trastuzumab; AC-Docetaxel Trastuzumab; AC-Taxotere/Herceptin;

NCIt related terms : AC-TH (Docetaxel); AC-TH (Docetaxel) (trastuzumab-pkrb); AC-TH (Docetaxel) (trastuzumab-dttb); AC-TH (Docetaxel) (trastuzumab-qyyp); AC-TH (Docetaxel) (trastuzumab-zerc); AC-TH (Docetaxel) (trastuzumab-dkst); AC-TH (Docetaxel) (trastuzumab-anns); AC-TH (Docetaxel) (trastuzumab-herw);

NCIt definition : A regimen consisting of cyclophosphamide and doxorubicin followed by docetaxel and trastuzumab, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer.;

NCIt note : Source: NCCN Guidelines 2017;

NCI Metathesaurus CUI : CL525008;

Codes from synonyms : 37198; 128938; 129423; 129326; 129229; 128841; 129132; 129035;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
30/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.